The effects of concurrent addition of methionine (Met) and glycine (Gly) to a 20% casein diet on serum lipoprotein profiles and fecal sterol excretion were studied in male Donryu rats with or without subcutaneous implantation of an ascites hepatoma line of AH109A cells. The hepatoma-bearing rats fed on the 20% casein diet had a notable elevation in the very-low-density lipoprotein+low-density lipoprotein (VLDL+LDL)-cholesterol (Ch) level with a slight but significant decrease in high-density lipoprotein (HDL)-Ch level when compared to the hepatoma-free (normal) rats fed on the same diet. The dietary addition of l.2% Met and 2.5% Gly in combination suppressed the hepatoma-induced elevation in the (VLDL+LDL)-Ch level with a prevention of the hepatoma-induced decrease in the HDL-Ch level. The addition of the two amino acids also lowered significantly the (VLDL+LDL)-Ch level without affecting the HDL-Ch level in tumor-free rats. Fecal excretion of both neutral and acidic sterols were reduced with growth of the hepatoma. The dietary addition of Met and Gly exerted no or little influence on neutral sterol excretion in both the tumor-free and -bearing states, but it enhanced acidic sterol excretion into feces in both states, especially in the hepatoma-bearing state at the last stage of feeding. These results suggest that the excretion and catabolism of Ch might be impaired in hepatoma -bearing rats with growth of the tumor, and that the supplemental Met and Gly in combination might enhance Ch catabolism by stimulating either synthesis or conjugation of bile acids, leading to a reduction of the (VLDL+LDL)-Ch level in the normal and hepatoma-bearing states.
Summary
The effects of concurrent addition of methionine (Met) and glycine (Gly) to a 20% casein diet on serum lipoprotein profiles and fecal sterol excretion were studied in male Donryu rats with or without subcutaneous implantation of an ascites hepatoma line of AH109A cells. The hepatoma-bearing rats fed on the 20% casein diet had a notable elevation in the very-low-density lipoprotein+low-density lipoprotein (VLDL+LDL)-cholesterol (Ch) level with a slight but significant decrease in high-density lipoprotein (HDL)-Ch level when compared to the hepatoma-free (normal) rats fed on the same diet. The dietary addition of l.2% Met and 2.5% Gly in combination suppressed the hepatoma-induced elevation in the (VLDL+LDL)-Ch level with a prevention of the hepatoma-induced decrease in the HDL-Ch level. The addition of the two amino acids also lowered significantly the (VLDL+LDL)-Ch level without affecting the HDL-Ch level in tumor-free rats. Fecal excretion of both neutral and acidic sterols were reduced with growth of the hepatoma. The dietary addition of Met and Gly exerted no or little influence on neutral sterol excretion in both the tumor-free and -bearing states, but it enhanced acidic sterol excretion into feces in both states, especially in the hepatoma-bearing state at the last stage of feeding. These results suggest that the excretion and catabolism of Ch might be impaired in hepatoma -bearing rats with growth of the tumor, and that the supplemental Met and Gly in combination might enhance Ch catabolism by stimulating either synthesis or conjugation of bile acids, leading to a reduction of the Various cancers have been documented to affect serum lipoprotein profiles in humans (1, 2) . Hepatoma is also known to induce abnormal serum lipid metabolism in humans (3, 4) and rats (5, 6 ). An enormous increase in the very-low-density lipoprotein+low-density lipoprotein (VLDL+LDL)-cholesterol (Ch) and a de crease in the high-density lipoprotein (HDL)-Ch were found in Donryu rats subcutaneously implanted with an ascites hepatoma line of AH109A cells (5) . The AH109A-induced abnormality in serum lipoprotein profiles was reported to be improved by adding either cystine (Cys), methionine (Met) , or Met and glycine (Gly) in combination (Met+Gly) to a 20% casein diet, but Gly alone exerted no influence on it (7). The reductive efficacy of Met alone on the hepatoma-induced hyper cholesterolemia was similar to that of Met+Gly or Cys alone . However, food intake and body weight gain of the Met group were the lowest among the amino acid-supplemented groups. Glycine was found to partially reduce this toxicity due to excess Met when it was concurrently supplemented with Met (7) . Thus, the combination of Met and Gly seems preferable to Met alone even though the reductive effect of Met and Gly in combination on the hepatoma-induced hyper cholesterolemia was equal to that of Met alone . Focusing attention on the combination of Met and Gly for the time being, we have been trying to clarify the mechanism for the induction of hypercholesterolemia by hepatoma and its improve ment by the amino acids from the aspect of Ch turnover (8) . In AH109A-bearing rats, the intestinal absorption of Ch was not enhanced , the cholesterogenesis in the host liver was increased, and the concomitant addition of Met and Gly exerted no influence on either absorption or synthesis of Ch (8) . These results suggest that an increased cholesterogenesis in the liver may be one cause of the hepatoma-induced increase in (VLDL+LDL)-Ch, and that Met and Gly in combination may suppress the increase in (VLDL+LDL)-Ch by a mechanism(s) other than reducing absorp tion and synthesis of Ch. This report describes the effect of supplemental Met and Gly on serum lipoprotein profiles and fecal sterol excretion in both normal and hepatoma-bearing rats. Lipid analyses. From the liver and solid hepatoma, total lipids were extracted according to the procedure of Folch et al. (9) , and the Ch (10), triglyceride (TG) (11) and phospholipid (PL)(12) levels were determined as described previously (13) . The serum TG level was also determined (I1).
MATERIALS AND METHODS

Animals
Lipoprotein separation and cholesterol determination. The serum lipoproteins were separated into HDL and VLDL+LDL fractions by the precipitation method (5). The total Ch contents of unfractionated whole serum (T-Ch) and HDL (HDL-Ch) were determined by an enzymatic method using a Cholesterol C -Test kit (Wako pure Chemical, Osaka), and the difference between T-Ch and HDL Ch was regarded as (VLDL+LDL)-Ch. 
RESULTS
As shown in Table I , the hepatoma implantation caused decreases in food intake, body weight gain, and relative liver weight (N vs. H), although none of the changes was significant. The concomitant addition of Met and Gly to the 20 casein diet increased these values (N vs. NMG, H vs. HMG), but all the differences were not significant. The hepatoma weight was unaffected by Met+Gly (H vs. HMG).
Changes in the serum lipid levels and atherogenic index (AI) [(VLDL+LDL) Ch/HDL-Ch] are illustrated in Fig. 1 . The serum TG and T-Ch levels were significantly elevated by AH109A implantation (N vs. H in Fig. 1, A and B) , confirming that the hepatoma endogenously induced both hypertriglyceridemia and hypercholesterolemia as previously reported (7) . The supplemental Met and Gly showed no significant effect on the serum TG level in both normal and hepatoma -bearing rats (Nvs. NMG, H vs. HMG in Fig. 1A ). These amino acids significantly Table 1 .
Values not sharing a common letter are significantly different at p<0,05. Table 1 . Values not sharing a common letter are significantly different at p<0 .05.
reduced the serum T-Ch level in the hepatoma-free , normal state (N vs. NMG in Fig. 1B ), while they caused only a weak lowering effect on the T-Ch level in the hepatoma-bearing state (H vs. HMG in Fig. 1B) . The hepatoma induced a notable elevation in the (VLDL+LDL)-Ch level and a significant decrease in the HDL-Ch level, resulting in a striking increase in AT (N vs. H in Fig . 1 , C, D, and E). In normal rats, the concurrent addition of Met and Gly significantly reduced the (VLDL+LDL)-Ch level without affecting the HDL-Ch level, leading to a decreas ing tendency of AI (N vs. NMG in Fig. 1 , C, D, and E). In hepatoma-bearing rats , the addition of the two amino acids significantly prevented the hepatoma-induced elevation of (VLDL+LDL)-Ch and the hepatoma-induced decrease in HDL-Ch , resulting in a notable reduction of AI (H vs. HMG in Fig , 1 , C, D, and E).
The liver and hepatoma lipid levels are shown in Table 2 . The hepatoma implantation caused a significant decreasing effect on the liver TG level but had no effect on the Ch and PL levels in the liver (N vs. H). The dietary addition of Met and Gly showed no influences on the liver TG, Ch, and PL levels in both the hepatoma -free and -bearing states (N vs. NMG, H vs. HMG). All the hepatoma lipids (TG, Ch, and PL) were not influenced by Met and Gly (H vs. HMG).
AND
SERUM LIPOPROTEINS 51 Figure 2 shows the fecal excretion of neutral and acidic sterols. As to fecal excretion of neutral sterols, no change was seen among four groups on days 5-7 ( Fig. 2A) , but a significant reduction was observed by hepatoma implantation on days 12-14 (N vs. H in Fig. 2B ). The addition of Met and Gly exerted noo influence on the excretion of neutral sterols in normal rats (N vs. NMG in Fig. 2, A and B) . In hepatoma-bearing rats, the two amino acids showed no (days 5-7) or little (days 12 -14) enhancing effect on the neutral sterol excretion (H vs. HMG in Fig. 2, A and B) . As to fecal excretion of acidic sterols (bile acids), it was unaffected on days 5-7 but was significantly suppressed on days 12-14 by the tumor implantation (N vs. H in Fig. 2, C and D) . The dietary addition of Met and Gly caused a stimulatory effect on bile acid excretion in both the normal (N vs. NMG in Fig. 2, C and D ) and hepatoma-bearing (H vs. HMG in Fig. 2, C and D) states, although such an effect of Met and Gly on bile acid excretion was not always significant.
DISCUSSION
In AH 109A-free (normal) rats, Met+Gly enhanced, though not significantly, the growth of rats by 49% (N vs. NMG in Table 1 ). An increase in food intake of the NMG group may, at least partly, explain the growth enhancement.
In the present study, the concurrent addition of Met and Gly was found to suppress the (VLDL+LDL)-Ch level not only in AH109A-bearing rats but also in AH109A-free rats (Fig. 1C) . Such an effect of Met and Gly in combination has also been reported in Ch-loaded rats fed on a 25% casein diet (17). The combination of Met and Gly exerted no influence on the HDL-Ch level in the tumor-free state, while it significantly prevented the AH109A-induced reduction of HDL-Ch in the tumor-bearing state. These changes in lipoprotein profiles resulted in a reduction of AI from the feeding of the two amino acids in both states, although the change was a decreasing tendency in the hepatoma-free state. Thus, the combination of Met and Gly seems competent for bettering lipoprotein profiles in both the hepatoma-free and-bearing states from the aspect of atherogenicity.
At the early stage (days 5-7) of feeding, fecal excretion of neutral and acidic sterols was almost the same extent between the hepatoma-free and -bearing groups (N vs. H in Fig. 2, A and C) . At the last stage (days 12-14) of feeding, however, their excretion was significantly suppressed in the hepatoma-bearing group compared to the hepatoma-free group (N vs. H in Fig. 2, B and D) . Fecal dry weight was similar among the four experimental groups (1.1-1.4g/rat), except for the hepatoma -bearing, 20% casein diet-fed (H) group at the last stage, in which group fecal weight was reduced by 30% compared to the hepatoma-free, 20% casein diet-fed (N) group (data not shown). Thus, the least excretion of feces in the H group might be attributable to the lowest excretion of neutral and acidic sterols at the last stage of feeding. The decreased food intake in the H group (Table 1 ) might be associated with the least excretion of feces among the four groups. Anyhow, the significant decrease in the fecal excretion of neutral and acidic sterols in hepatoma-bearing rats at the last stage suggests that Ch excretion and/or catabolism may be impaired with growth of the tumor. A possibility that an enhanced reabsorption of neutral and acidic sterols across the intestine might apparently reduce the fecal excretion of the sterols can be ruled out, since the Ch absorption measured by the dual-isotope method (18) was almost the same between the H and N groups (8) .
The concomitant addition of Met and Gly to the 20% casein diet exerted no or little influence on the fecal excretion of neutral sterols in both the tumor-free and -bearing states compared to the corresponding control groups (Fig . 2, A and B) . In contrast, the two amino acids in combination, as a rule, showed an enhancing effect on the fecal excretion of bile acids in both the hepatoma-free and -bearing states (Fig. 2, C and D) . These results suggest that the addition of Met and Gly in combination stimulates the coversion of Ch to bile acids and/or the conjugation of bile acids in the host liver of tumor-bearing rats as well as the normal liver of tumor -free rats. Two pathways are known for Met catabolism, i.e., the transsulfuration pathway and transaminative pathway (19) . The latter pathway is suggested to be responsible for the toxicity of excess Met (20) . Supplemental Gly has been shown to alleviate this toxicity (20, 21) There is another intriguing question to be answered in AH109A-bearing rats: Why does HDL decrease in the host serum? and How does the concurrent addition of Met and Gly prevent the hepatoma-induced decrease in HDL? Nikkila et al . (24) reported the presence of a positive correlation between adipose tissue lipoprotein lipase (LPL) activity and HDL-Ch concentration. Patsch et al . (25) demonstrated the formation of an HDL2-like lipoprotein by incubating in vitro VLDL and HDL3 with purified LPL. These findings indicate that LPL activity affects the quantity and quality of HDL, as well as the catabolism of TG-rich lipoproteins. In mice bearing a GRSL scites tumor (a murine leukemia model), the LPL activity has been reported to decrease (26) . Thus, measurements of the LPL activity in AH109A-bearing rats seem worthy of consideration when determining the reason not only for the reduction of HDL-Ch in rats bearing the hepatoma but also for the prevention of the hepatoma-induced decrease in HDL-Ch by Met and Gly in combination . 
